Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

NCT06241755 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

412

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Muscle Invasive Bladder Cancer

Interventions

DRUG: BCG for Therapeutic Use
DRUG: BCG for Therapeutic Use

Sponsor

Chengdu CoenBiotech Co., Ltd

Collaborators

[object Object]